Mycophenolate mofetil as first-line treatment improves clinically evident early scleroderma lung disease. [electronic resource]
Producer: 20061107Description: 1005-8 p. digitalISSN:- 1462-0324
- Adolescent
- Adult
- Anti-Inflammatory Agents, Non-Steroidal -- adverse effects
- Drug Therapy, Combination
- Female
- Glucocorticoids -- therapeutic use
- Humans
- Male
- Middle Aged
- Mycophenolic Acid -- adverse effects
- Prednisolone -- therapeutic use
- Prospective Studies
- Pulmonary Diffusing Capacity -- drug effects
- Pulmonary Fibrosis -- diagnostic imaging
- Scleroderma, Diffuse -- complications
- Tomography, X-Ray Computed
- Treatment Failure
- Vital Capacity -- drug effects
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.